Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Afterload
10%
Anatomical Concepts
50%
Arterial Pressure
10%
Biological Marker
24%
Care Pathway
7%
Clinical Assessment
7%
Clinical Pathway
7%
Congestive Heart Failure
7%
CYP2C19
7%
Disease Exacerbation
10%
Drug Therapy
10%
Heart Function
10%
Heart Left Ventricle Outflow Tract Obstruction
50%
Heart Performance
50%
Heart Ventricle Ejection
7%
Hemodynamic
10%
Hypertrophic Cardiomyopathy
100%
Hypertrophic Obstructive Cardiomyopathy
7%
Maintenance Drug Dose
21%
Mavacamten
70%
Myocardium
7%
New York Heart Association Class
14%
Pharmacological Treatment
10%
Physiology
10%
Targeted Therapy
7%
Treatment Interruption
7%
Treatment Response
20%
Ventricular Hypertrophy
10%
Ventricular Outflow Tract
21%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
24%
Congestive Heart Failure
7%
CYP2C19
7%
Disease Exacerbation
10%
Heart Left Ventricle Outflow Tract Obstruction
50%
Heart Ventricle Hypertrophy
10%
Hypertrophic Cardiomyopathy
100%
Hypertrophic Obstructive Cardiomyopathy
7%
Maintenance Dose
21%
Mavacamten
70%